Press release
Peripheral Vasodilator Drugs Market Report 2024-2033 | Size, Share, Trends, Growth Demand, Overview
Peripheral Vasodilator Drugs Market Trends
As per the report, the peripheral vasodilator drugs market size has grown strongly in recent years. It will grow from $5.92 billion in 2023 to $6.27 billion in 2024 at a compound annual growth rate (CAGR) of 6%. The peripheral vasodilator drugs market size is expected to see strong growth in the next few years. It will grow to $7.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16508&type=smp
Rising Cardiovascular Disease Prevalence Fuels Growth Of Peripheral Vasodilator Market
An increase in the prevalence of cardiovascular diseases is expected to propel the growth of the peripheral vasodilator drug market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, often caused by atherosclerosis, leading to conditions like heart attacks, strokes, hypertension, and heart failure. The cases of cardiovascular diseases arise primarily due to sedentary lifestyles, unhealthy diets, aging populations, rising rates of obesity, and related health conditions such as diabetes and hypertension. Peripheral vasodilators in cardiovascular diseases improve blood flow, reduce blood pressure, decrease the heart's workload, and alleviate symptoms of conditions such as peripheral arterial disease. For instance, in January 2024, according to an article published by the American Heart Association, a US-based nonprofit organization focused on cardiovascular medical research, cardiovascular disease caused 931,578 deaths in the US, slightly more than the 928,741 in 2020. Globally, there were 19.91 million CVD deaths in 2021, compared to 19.05 million in 2020. Therefore, the increase in the prevalence of cardiovascular diseases is driving the growth of the peripheral vasodilator drug market.
Innovation In Peripheral Vasodilator Market With Advanced Drug Development
Major companies operating in the peripheral vasodilator drugs market are focusing on drug development with triple-drug combination therapies to optimize treatment outcomes and expand market share in cardiovascular therapeutics. Triple-drug combination therapy is an antihypertensive FDC that targets patients who have not achieved adequate blood pressure control with dual-drug therapies or are unable to tolerate diuretic-based combinations. For instance, in August 2023, Ajanta Pharma Limited, an India-based pharmaceutical company specializing in cardiology, introduced Met XL AMT, a novel triple-drug combination to manage hypertension among Indian patients. It is a fixed-dose combination (FDC) of three antihypertensive agents, including Telmisartan, Amlodipine, and Metoprolol. These agents work together to lower blood pressure by relaxing blood vessels, which is a characteristic of peripheral vasodilators. The drug is specifically approved by DCGI for managing uncontrolled hypertension alongside stable coronary artery disease, making it the world's first fixed-dose combination (FDC) of metoprolol succinate (extended-release) 50 mg, amlodipine 5 mg, and telmisartan 40 mg.
The peripheral vasodilator drugs market covered in this report is segmented -
1) By Drug Type: Calcium Channel Blockers, Direct-Acting Vasodilators, Alpha-Adrenergic Blockers, Potassium Channel Activators, Nitrates, Other Types
2) By Indication: Hypertension, Angina, Heart Failure, Other Indications
3) By Application: Hospital, Retail Pharmacies, Other Applications
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16508&type=discount
Major companies operating in the peripheral vasodilator drugs market are Pfizer Inc., Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Takeda Pharmaceutical Company, Gilead Sciences Inc, Amgen Inc, Boehringer Ingelheim International GmbH, Merck & Co, Viatris Inc., Baxter, Teva Pharmaceutical Industries, Astellas Pharma, Daiichi Sankyo Company, Limited, Sun Pharmaceutical Industries, Mitsubishi Tanabe Pharma, Cipla Limited, Hikma Pharmaceuticals, Lupin Pharmaceuticals, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Ipca Laboratories, Alembic Pharmaceuticals
Contents of the report:
1. Executive Summary
2. Peripheral Vasodilator Drugs Market Report Structure
3. Peripheral Vasodilator Drugs Market Trends And Strategies
4. Peripheral Vasodilator Drugs Market - Macro Economic Scenario
5. Peripheral Vasodilator Drugs Market Size And Growth
…..
27. Peripheral Vasodilator Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/peripheral-vasodilator-drugs-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peripheral Vasodilator Drugs Market Report 2024-2033 | Size, Share, Trends, Growth Demand, Overview here
News-ID: 3618938 • Views: …
More Releases from The Business Research Company
Brake Lines Market Analysis: $36.58 Billion by 2029 With a CAGR of 3.5%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Brake Lines Market Value Projection: How Much Will the Market Size by 2025?
In recent times, the brake lines market has consistently seen growth. The market size is expected to escalate from $30.83 billion in 2024 to $31.88 billion in 2025, growing at a compound annual growth rate (CAGR) of 3.4%.…
Autonomous Vehicle Simulation Solutions Industry Set to Achieve $2.12 Billion Mi …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Autonomous Vehicle Simulation Solutions Market Size 2025?
The market size for autonomous vehicle simulation solutions has seen a rapid expansion in the past few years. The market, with a value of $0.96 billion in 2024, is projected to rise to $1.14 billion in 2025,…
Automotive Vehicle To Everything (V2X) Communications Industry Expected to Reach …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Automotive Vehicle To Everything (V2X) Communications Market Value Projection: How Much Will the Market Size by 2025?
In recent years, the size of the automotive vehicle to everything (v2x) communications market has seen substantial growth. It is projected to increase from $3.6 billion in 2024 to $4.43 billion in 2025, registering…
Global Highway Driving Assist Market Worth $11.2 Billion by 2029, Growing at 20% …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Highway Driving Assist Market Outlook: What Size And CAGR Are Anticipated By 2025?
There has been a rapid expansion in the size of the highway driving assist market in the previous few years. Its projected growth is from $4.47 billion in 2024, escalating to $5.39 billion in 2025, with a…
More Releases for Peripheral
Peripheral Vascular Devices Market - Advancing vascular health: Cutting-edge dev …
Newark, New Castle, USA: The "Peripheral Vascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Peripheral Vascular Devices Market: https://www.growthplusreports.com/report/peripheral-vascular-devices-market/7820
This latest report researches the industry structure,…
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive…
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele …
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview of…
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations.
Request for Sample of This Research Report @ https://bit.ly/2xjOKpC
Top Key Player:-
Abbott Laboratories
Braun Melsungen AG
Boston Scientific Corporation
R. Brad, Inc.
Cardinal Health, Inc.
Medtronic plc.
Cook Medical, Inc.
Teruma Corporation
Jude Medical, Inc.
The Spectranetics Corporation
Volcano Corporation
Peripheral vascular disorder (PVD) is a blood circulation disorder…
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.
Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533
The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a…
